Why the study?
Functional mitral regurgitation worsens morbidity and mortality in heart failure, and cardiac resynchronization therapy can reduce it by targeting dyssynchrony and reverse remodeling.
What are the predictors of functional mitral regurgitation improvement after cardiac resynchronization therapy in heart failure patients?
What are the predictors of functional mitral regurgitation improvement after cardiac resynchronization therapy in heart failure patients?
This review summarizes the literature on predictors of functional mitral regurgitation improvement following cardiac resynchronization therapy in heart failure patients.
CRT may mitigate functional MR in eligible HF patients; leaves open outcome benefits pending dedicated RCTs.
Functional mitral regurgitation is a common finding among heart failure patients with ischemic and non-ischemic dilated cardiomyopathies. The presence of moderate or severe mitral regurgitation is associated with higher morbidity and mortality. Heart failure patients meeting electrocardiogram and left ventricle function criteria are good candidates for cardiac resynchronization therapy, which may reduce the degree of functional mitral regurgitation in the short and long term, specifically targeting myocardial dyssynchrony and inducing left ventricle reverse remodeling. In this article, we analyze data from the literature about predictors of mitral regurgitation improvement after cardiac resynchronization therapy implantation.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: